Non-cystic-fibrosis bronchiectasis in children: A persisting problem in developing countries

被引:117
作者
Karadag, B
Karakoc, F
Ersu, R
Kut, A
Bakac, S
Dagli, E
机构
[1] SSK Goztepe Training Hosp, Div Pediat Pulmonol, Istanbul, Turkey
[2] Marmara Univ, Div Pediat Pulmonol, Istanbul, Turkey
关键词
children; bronchiectasis; management;
D O I
10.1159/000085362
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Non-cystic-fibrosis (non-CF) bronchiectasis in childhood is still one of the most common causes of childhood morbidity in developing countries. The management of these patients remains problematic, and there are few studies of long-term outcome. Objective: The aim of this retrospective study was to define the general characteristics, underlying causative factors and long-term follow-up results of non-CF bronchiectasis patients. Methods: One hundred and eleven consecutive children, diagnosed with non-CF bronchiectasis were included in the study. General characteristics and underlying causes were recorded from the medical records. Clinical outcomes were evaluated in terms of lung function tests, annual exacerbation rates and patient/parent perception of health status. Results: Mean age of the patients was 7.4 +/- 3.7 years at presentation, and patients had been followed 4.7 +/- 2.7 years on average. In 62.2% of the patients, an underlying etiology was identified, whereas postinfectious bronchiectasis was the most common (29.7%). In spite of intensive medical treatment, 23.4% of the patients required surgery. The annual lower respiratory infection rate has decreased from a mean of 6.6 +/- 4.0 to 2.9 +/- 2.9 during follow-up ( p < 0.0001). Lung function tests were also found to be improved (mean FEV1 % 63.3 +/- 21.0 vs. 73.9 +/- 27.9; p = 0.01; mean FVC% 68.1 +/- 22.2 vs. 74.0 +/- 24.8; p = 0.04). There was clinical improvement in both the surgical (73%) and medical (70.1%) groups ( p > 0.05). Conclusion: In conclusion, bronchiectasis remains a disease of concern to pediatricians, particularly in developing countries. Infections are still important causes of bronchiectasis, and clinical improvement can be achieved by appropriate treatment. Although medical treatment is the mainstay of management, surgery should be considered in selected patients. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107
[2]   BRONCHIECTASIS - UPDATE OF AN ORPHAN DISEASE [J].
BARKER, AF ;
BARDANA, EJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (04) :969-978
[3]   Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis [J].
Barker, AF ;
Couch, L ;
Fiel, SB ;
Gotfried, MH ;
Ilowite, J ;
Meyer, KC ;
O'Donnell, A ;
Sahn, SA ;
Smith, LJ ;
Stewart, JO ;
Abuan, T ;
Tully, H ;
Van Dalfsen, J ;
Wells, CD ;
Quan, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :481-485
[4]  
BASARAN N, 1988, CLIN GENET, V34, P339
[5]  
BROWN MA, 1998, KENDIGS DISORDERS RE, P538
[6]   CILIARY ABNORMALITIES IN RESPIRATORY-DISEASE [J].
BUCHDAHL, RM ;
REISER, J ;
INGRAM, D ;
RUTMAN, A ;
COLE, PJ ;
WARNER, JO .
ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (03) :238-243
[7]   Bronchiectasis in children: Orphan disease or persistent problem? [J].
Callahan, CW ;
Redding, GJ .
PEDIATRIC PULMONOLOGY, 2002, 33 (06) :492-496
[8]   Bronchiectasis in Indigenous children in remote Australian communities [J].
Chang, AB ;
Grimwood, K ;
Mulholland, EK ;
Torzillo, PJ .
MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (04) :200-204
[9]  
Dagli E, 2000, Paediatr Respir Rev, V1, P64, DOI 10.1053/prrv.2000.0011
[10]  
FERKOL TW, 1999, PEDIAT RESP MED, P784